Cargando…
Systemic side effects of eye drops: a pharmacokinetic perspective
When administering eye drops, even when completely correctly applied, several routes of absorption are possible and excess amounts can sometimes cause an unwanted systemic bioavailability of the drops when not completely absorbed into the eye. Furthermore, the concentration of active ingredients in...
Autores principales: | Farkouh, Andre, Frigo, Peter, Czejka, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153265/ https://www.ncbi.nlm.nih.gov/pubmed/27994437 http://dx.doi.org/10.2147/OPTH.S118409 |
Ejemplares similares
-
Sex-Related Differences in Drugs with Anti-Inflammatory Properties
por: Farkouh, André, et al.
Publicado: (2021) -
Biopolymers in Mucoadhesive Eye Drops for Treatment of Dry Eye and Allergic Conditions: Application and Perspectives
por: Račić, Anđelka, et al.
Publicado: (2023) -
Pharmacokinetic interaction between epirubicin and the multidrug resistance reverting agent D-verapamil.
por: Scheithauer, W., et al.
Publicado: (1993) -
Bio-Distribution and Pharmacokinetics of Topically Administered γ-Cyclodextrin Based Eye Drops in Rabbits
por: Kallab, Martin, et al.
Publicado: (2021) -
The use of preservatives in dry eye drops
por: Walsh, Karen, et al.
Publicado: (2019)